Tarsheen Sethi, MD, MSc
Assistant Professor of Medicine (Hematology); Director, Yale Affiliated Hospital Program for Hematology Section, Internal Medicine
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Tarsheen Sethi, MD, MSCI, is an Assistant Professor of Medicine (Hematology) and cares primarily for patients with Hodgkin and Non-Hodgkin lymphomas. Under the mentorship of Dr. Francine Foss, Dr. Sethi sees patients of all lymphoma subtypes, including T-cell lymphomas and Chronic Leukocytic Leukemia. Dr. Sethi joined Smilow from Vanderbilt University Medical School where she was an Instructor of Medicine in their Division of Hematology-Oncology.
Dr. Sethi received her Medical Degree from the Maulana Azad Medical College in New Delhi, India, and her Master of Science in Clinical Investigation at Vanderbilt University, where she also completed her fellowship in Hematology-Oncology. As a post-doctoral research fellow at the Stanford Molecular Imaging Program, Dr. Sethi received the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Award in Translational Medicine and Therapeutics. With this research training background, she is involved in clinical and translational research projects aimed at improving care and outcomes of Hodgkin and Non-Hodgkin lymphoma patients. Dr. Sethi’s research includes clinical trials targeting lymphomas involving novel drugs and combinations. She is also interested in studying the applications of tumor immunology and immunotherapy to hematologic malignancies, focusing on lymphoma.
Education & Training
- Clinical Fellow and Advanced FellowVanderbilt University Medical Center (2018)
- MScVanderbilt University, Clinical Investigation (2018)
- Intern and Resident PhysicianUniversity of Louisville (2013)
- Chief ResidentMaulana Azad Medical College (2009)
- MDMaulana Azad Medical College (2008)
- Resident PhysicianMaulana Azad Medical College (2008)
- MBBSMaulana Azad Medical College (2005)
Activities
- : Clinical Correlates of Response with Mogamulizumab in MF/SS: Skin Flare and LymphopeniaHybrid Meeting 2022United States cutaneous lymphoma consortium (USCLC) 2022
- Efficacy and Safety of EPOCH in Aggressive T-Cell Lymphomas- A Real World AnalysisVirtual Meeting 2021T-cell Forum 2021
- T-Cell Lymphoma Case PresentationLymphoma Research Foundation New England Lymphoma Rounds 2021Lymphoma Research Foundation New England Lymphoma Rounds
- Efficacy and Safety of EPOCH in Aggressive Presentations of Cutaneous T-Cell LymphomasUSCLC 2021United States cutaneous lymphoma consortium (USCLC) 2021
- Advances in Treatment of Primary Central Nervous System LymphomaHouston, TX, United States 2020Division of Hematology/Oncology Seminar, Baylor College of Medicine, Houston TX
- Beyond Chemotherapy: Novel Approach to Treatment of Primary Central Nervous System LymphomaPortland, OR, United States 2020, OHSU Knight Cancer Institute-Center for Hematologic Malignancies Grand Rounds
- Update in Management of Primary Central Nervous System LymphomaBuffalo, NY, United States 2019Division of Hematology/Oncology Seminar, Roswell Park Cancer Institute, Buffalo, NY
- Combination of Nivolumab, Lenalidomide and Rituximab in Relapsed/Refractory Non-Germinal Center Diffuse Large B Cell Lymphoma: Results from a Dose-Escalation CohortOrlando, FL, United States 2019ASH Annual Meeting 2019
- Correlation of Toll-like Receptor (TLR) and PD-1 Pathways in Central Nervous System Lymphoma: A Clinicopathological Study on OutcomesHouston, TX, United States 2018Immuno-Oncology Young Investigator’s Forum
- Incidence of Central Nervous System (CNS) Relapse in MYC Rearranged Diffuse Large B-Cell Lymphoma: Does CNS Prophylaxis Improve Outcome?Atlanta, GA, United States 2017ASH Annual Meeting
- Correlation of Toll-like Receptor (TLR) and PD-1 Pathways in Central Nervous System Lymphoma: A Clinicopathological Study on OutcomesSan Diego, CA, United States 2016ASH Annual Meeting 2016
- Interim Absolute Lymphocyte Count (ALC) As a Predictor of Survival in Hodgkin LymphomaOrlando, FL, United States 2015ASH Annual Meeting
- Differences in Outcome of Patients with Syncytial Variant Hodgkin Lymphoma Compared with Typical Nodular Sclerosis HLOrlando, FL, United States 2015ASH Annual Meeting 2015
- Imaging of Tumor Associated Macrophages In Pediatric Patients with Malignant Lymphomas and SarcomasChicago, IL, United States 2014Radiological Society of North America (RSNA), Scientific Assembly and Annual Meeting
- Albuterol: A Double-Edged Sword?Louisville, KY, United States 2013American College of Physicians KY
- Thrombosis of a Different Kind Causing ST Segment ElevatioLouisville, KY, United States 2012American College of Cardiology KY Meeting
- Activation of Macrophages and Dendritic Cells by β-Glucans from Various Sources: A Murine StudyLouisville, KY, United States 2012Research Louisville 2012
- Complete Duodenal Obstruction: An unusual presentation of Castlemans DiseaseNew Orleans, LA, United States 2012Southern Society of General Internal Medicine (SSGIM)
- Not so benign: A case of non-Hodgkin lymphoma masquerading as meningitisLouisville, KY, United States 2011American College of physicians KY
- Chemobrain: A case of non-small cell lung cancer with chemotherapy induced cognitive impairmentNational, MD, United States 2011American Geriatric Society Meeting
- To test the hypothesis that hypoxemic episodes in obstructive sleep apnea cause myocyte necrosis by estimating cardiac troponin TKochi, KL, India 2008Annual Conference of The Association of Physicians of India (APICON)
- Clinicobacteriological Study of Intensive Care Unit (ICU) Acquired InfectionsKochi, KL, India 2008Annual Conference of The Association of Physicians of India (APICON)
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| AACR/ASCO VAIL Methods in Clinical Cancer Research (MCCR) | 2017 | |
| Abstract Achievement Award | American Society of Hematology | 2016 |
| Post Doctoral Fellowship in Translational Medicine and Therapeutics | Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation | 2013 |
| Award for the highest score in the Internal Medicine in-service exam among PGY3 residents | University of Louisville | 2013 |
| Award for the highest score in the Internal Medicine in- service exam among PGY2 residents | University of Louisville | 2012 |
| Award for the highest score in the Internal Medicine in- service exam among PGY1 residents | University of Louisville | 2011 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| New England Hematologic Malignancies Symposium | Abstract Reviewer | 2023 - Present |
| The DeLuca Center for Innovation in Hematology Research Seminar Series | Co-Director | 2023 - Present |
| “ASCO Reading Room" section of MedPage Today | Reviewer | 2023 - Present |
| HIV-Cancer Focus Group | Member | 2022 - Present |
| Yale Cancer Center Protocol Review Committee (PRC) | Member | 2022 - Present |
| Yale Affiliated Hospitals Program (YAHP)-Hematology | Director | 2022 - Present |
| Cancer Journal | Reviewer | 2021 - Present |
| American Society of Hematology Annual Meeting 2021 | Session Name: 624. Hodgkin Lymphomas and T/NK cell Lymphomas: T/NK Cell Lymphoma Relapsed Therapy Session Date: Monday, December 13, 2021 Session Time: 10:30 AM - 12:00 PM Eastern time Room: Georgia World Congress Center, Hall A1 | 2021 |
| National Comprehensive Cancer Center (NCCN) Histiocytosis Panel | Member | 2019 - 2020 |
| HemOnc.org Aggressive Lymphomas Section | Reviewing Editor | 2019 - Present |
| Clinical Lymphoma Myeloma and Leukemia | Reviewer | 2017 - Present |
| American Association for Cancer Research | Member | 2017 - 2019 |
| British Journal of Hematology | Reviewer | 2015 - Present |
| Bone Marrow Transplantation | Reviewer | 2015 - Present |
| American Society of Hematology | Member | 2014 - Present |
| American Society of Cancer Oncology | Member | 2014 - Present |
| American College of Physicians | Member | 2010 - 2013 |
Departments & Organizations
- Hematology
- Internal Medicine
- Leukemia & Lymphoma Program
- Yale Cancer Center
- Yale Medicine